Effects of risperidone and quetiapine on cognition in patients with schizophrenia and predominantly negative symptoms

References

Page 1

	Year	Citations
Validity of the Trail Making Test as an Indicator of Organic Brain Damage Ralph M. Reitan Perceptual and Motor Skills NeuropsychologyBrain FunctionMedicineBrain InjuryNeurology	1958	7.5K
Clozapine for the Treatment-Resistant Schizophrenic John M. Kane Archives of General Psychiatry	1988	4.1K
Dementia Praecox and Paraphrenia. Annals of Internal Medicine Geriatric PsychiatryPsychiatric DisordersNeuropsychiatryGigantic TextbookDementia Praecox	1972	2.9K
The NIMH-MATRICS Consensus Statement on Negative Symptoms Bill Kirkpatrick, Wayne S. Fenton, William T. Carpenter, Schizophrenia Bulletin Psychological Co-morbiditiesNeuropsychologyPsychiatric DisordersPsychotropic MedicationPsychopharmacology	2006	1.3K
Auditory Working Memory and Wisconsin Card Sorting Test Performance in Schizophrenia James M. Gold Archives of General Psychiatry	1997	824
Olanzapine versus Placebo and Haloperidol Charles M. Beasley, Gary D. Tollefson, P. Tran, Neuropsychopharmacology PsychiatryPsychotropic MedicationClinical PsychologyPsychopharmacologyNeuropharmacology	1996	785
Multiple fixed doses of “Seroquel” (quetiapine) in patients with acute exacerbation of schizophrenia: A comparison with haloperidol and placebo Lisa A. Arvanitis, B.G. Miller Biological Psychiatry Multiple Fixed Doses“ Seroquel ”PsychiatryPsychotic DisorderPsychotropic Medication	1997	779
Stability and Course of Neuropsychological Deficits in Schizophrenia Robert K. Heaton, Julie Akiko Gladsjo, Barton W. Palmer, Archives of General Psychiatry	2001	615
Cognitive Enhancement Therapy for Schizophrenia Gerard E. Hogarty, S. Flesher, Richard F. Ulrich, Archives of General Psychiatry	2004	539
Neurocognitive Effects of Clozapine, Olanzapine, Risperidone, and Haloperidol in Patients With Chronic Schizophrenia or Schizoaffective Disorder Robert M. Bilder, Robert Goldman, Jan Volavka, American Journal of Psychiatry	2002	537

Page 1